FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
CTS communications distributed on July 6th and July 20th.In working with Grifols on the availability...
Creative Testing Solutions, the largest nonprofit blood testing organization in the U.S., today anno...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...